Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cu Medical Systems Inc. (115480:KRX), powered by AI.
Cu Medical Systems Inc. is currently trading at ₩1,934. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Cu Medical Systems Inc. on Alpha Lenz.
Cu Medical Systems Inc.'s P/E ratio is 28.6.
“Cu Medical Systems Inc. trades at a P/E of 28.6 (premium valuation) with modest ROE of 1.4%. Operating margin of 23.0% indicates strong profitability.”
Ask for details →Cu Medical Systems Inc. is a healthcare technology company specializing in the development and manufacture of advanced emergency medical equipment. This firm is primarily known for producing automated external defibrillators (AEDs) that are essential in providing life-saving interventions for cardiac arrest situations. Their products are widely used in hospitals, emergency services, and public spaces, reflecting their importance in critical life-saving scenarios. Cu Medical also offers a range of accessories and consumables necessary for the efficient operation of their equipment, thereby ensuring comprehensive support for their healthcare partners. The company's innovations have significant impacts on the healthcare sector, contributing to emergency preparedness and community health awareness. As a player in the medical equipment industry, Cu Medical Systems Inc. supports the global healthcare infrastructure, helping professionals and laypersons alike to respond quickly and effectively to emergencies. Their role in the market is integral to the development of accessible and reliable emergency treatment solutions, which are vital to improving survival rates in cardiac emergencies.
“Cu Medical Systems Inc. trades at a P/E of 28.6 (premium valuation) with modest ROE of 1.4%. Operating margin of 23.0% indicates strong profitability.”
Ask for details →Cu Medical Systems Inc. (ticker: 115480) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $23.4B.
The current price is ₩1,934 with a P/E ratio of 28.62x and P/B of 0.39x.
ROE is 1.38% and operating margin is 22.96%. Annual revenue is $48.2B.